Correlation Between Denali Therapeutics and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Editas Medicine, you can compare the effects of market volatilities on Denali Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Editas Medicine.
Diversification Opportunities for Denali Therapeutics and Editas Medicine
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Denali and Editas is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Editas Medicine go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Editas Medicine
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.85 times more return on investment than Editas Medicine. However, Denali Therapeutics is 1.18 times less risky than Editas Medicine. It trades about 0.02 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.06 per unit of risk. If you would invest 2,346 in Denali Therapeutics on November 1, 2024 and sell it today you would earn a total of 12.00 from holding Denali Therapeutics or generate 0.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Editas Medicine
Performance |
| Timeline |
| Denali Therapeutics |
| Editas Medicine |
Denali Therapeutics and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Editas Medicine
The main advantage of trading using opposite Denali Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |